Top 5 Stock Picks of Joel Ramin’s 12 West Capital

2. 10x Genomics, Inc. (NASDAQ:TXG)

Mr. Ramin’s Stake Value: $376 million

Percentage of Mr. Ramin’s 13F Portfolio: 15.77%

Number of Hedge Fund Holders: 28

10x Genomics, Inc. (NASDAQ:TXG) is a lifescience firm that manufacturers and sells equipment and software for analyzing biological systems. Some of the instruments that it provides are chromium instruments, slides, reagents, and microfluidic chips.
By the end of the second quarter of this year, Mr. Ramin’s investment firm held 1.9 million shares of 10x Genomics, Inc. (NASDAQ:TXG) that were worth $376 million and which represented 15.77% of the fund’s portfolio. At the same time, 28 of the 873 hedge funds polled by Insider Monkey held a stake in the company.

10x Genomics, Inc. (NASDAQ:TXG)’s largest shareholder is Catherine D. Wood’s ARK Investment Management who owns 4.3 million shares worth $842 million.

In its third quarter 2021 earnings report, 10x Genomics, Inc. (NASDAQ:TXG) reported $125 million in revenue and -$0.15 in GAAP EPS, beating analyst estimates for both. BofA downgraded the company’s shares to Neutral in a September 2021 analyst note with a $180 price target, sharing that a ‘negative tone’ during earnings cast a shadow on the company’s future.